What is Novastep?
Novastep International operates as a high-growth medical device enterprise dedicated to the advancement of foot and ankle surgical solutions. The company distinguishes itself through the development of proprietary technologies, including the PECA MIS Bunion Correction and the AIRLOCK Plating System. These innovations are engineered to address critical gaps in orthopedic care, focusing on minimally invasive techniques that prioritize patient recovery and surgical precision. By targeting specialized healthcare institutions and orthopedic surgeons, Novastep has established a reputation for delivering disruptive, high-efficiency tools that improve clinical outcomes in a demanding medical market.
How much funding has Novastep raised?
Novastep has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Novastep
PPP
Public-Private Partnership
What's next for Novastep?
With the recent influx of capital, Novastep is poised to enter a new phase of operational scaling. The strategic roadmap likely involves expanding its international distribution network and investing in further research and development to broaden its portfolio of surgical implants. As the company transitions from its current growth stage toward broader market penetration, the focus will remain on maintaining its competitive edge through technological differentiation. Future initiatives will likely prioritize the integration of its surgical systems into major hospital networks, thereby enhancing its market share and reinforcing its commitment to orthopedic excellence.
See full Novastep company page
